The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 59,641 | 3,495,943 | SH | SOLE | 3,495,943 | 0 | 0 | ||
5 01 ACQUISITION CORP | COM CL A | 33836P105 | 1,970 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 1,940 | 485,005 | SH | SOLE | 485,005 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 145,114 | 5,991,479 | SH | SOLE | 5,991,479 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 1,371 | 1,046,700 | SH | SOLE | 1,046,700 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 9,386 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 81,773 | 5,738,448 | SH | SOLE | 5,738,448 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 8,489 | 3,948,360 | SH | SOLE | 3,948,360 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 186,070 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 263,370 | 5,183,431 | SH | SOLE | 5,183,431 | 0 | 0 | ||
APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 990 | 131,693 | SH | SOLE | 131,693 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 17,247 | 895,503 | SH | SOLE | 895,503 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 103,047 | 3,265,101 | SH | SOLE | 3,265,101 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 39,414 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 101,214 | 1,503,929 | SH | SOLE | 1,503,929 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,470 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 45,779 | 6,340,639 | SH | SOLE | 6,340,639 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 1,137 | 358,780 | SH | SOLE | 358,780 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 50,968 | 2,759,505 | SH | SOLE | 2,759,505 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,974 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 24,022 | 547,453 | SH | SOLE | 547,453 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 411 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 4,852 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 747 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 689 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 4,077 | 454,545 | SH | SOLE | 454,545 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 57,636 | 1,646,260 | SH | SOLE | 1,646,260 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 11,288 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 17,345 | 790,209 | SH | SOLE | 790,209 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 38,299 | 2,371,445 | SH | SOLE | 2,371,445 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 2,073 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 22,890 | 2,359,808 | SH | SOLE | 2,359,808 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 5,835 | 678,441 | SH | SOLE | 678,441 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 1,968 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 656 | 66,666 | SH | Call | SOLE | 66,666 | 0 | 0 | |
EXELIXIS INC | COM | 30161Q104 | 21,567 | 951,333 | SH | SOLE | 951,333 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 655 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO CL A | SHS | G3710A105 | 5,776 | 587,615 | SH | SOLE | 587,615 | 0 | 0 | ||
PARDES BIOSCIENCES INC | COM | 69945Q105 | 1,394 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 198,193 | 3,195,624 | SH | SOLE | 3,195,624 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 19,429 | 14,285,714 | SH | SOLE | 14,285,714 | 0 | 0 | ||
GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 3,634 | 1,559,710 | SH | SOLE | 1,559,710 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 5,224 | 1,024,279 | SH | SOLE | 1,024,279 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 ORD | SHS | G4411D109 | 3,964 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,220 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HOOKIPA PHARMA INC | COM | 43906K100 | 11,400 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 7,981 | 298,597 | SH | SOLE | 298,597 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 2,343 | 72,821 | SH | SOLE | 72,821 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 20,382 | 1,421,319 | SH | SOLE | 1,421,319 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,915 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 1,971 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 2,363 | 326,780 | SH | SOLE | 326,780 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 106,745 | 6,638,371 | SH | SOLE | 6,638,371 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,303 | 326,578 | SH | SOLE | 326,578 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 41,161 | 500,622 | SH | SOLE | 500,622 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 158,655 | 3,951,566 | SH | SOLE | 3,951,566 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 8,252 | 541,108 | SH | SOLE | 541,108 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 3,565 | 254,473 | SH | SOLE | 254,473 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 5,067 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 73,096 | 13,896,543 | SH | SOLE | 13,896,543 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 491 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 18,252 | 3,418,068 | SH | SOLE | 3,418,068 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 19,209 | 6,117,400 | SH | SOLE | 6,117,400 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 13,529 | 649,786 | SH | SOLE | 649,786 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 9,039 | 381,711 | SH | SOLE | 381,711 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 423,637 | 11,584,280 | SH | SOLE | 11,584,280 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 309 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 64,721 | 1,975,611 | SH | SOLE | 1,975,611 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 68,583 | 2,291,441 | SH | SOLE | 2,291,441 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 712 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 32,502 | 1,274,097 | SH | SOLE | 1,274,097 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 161,680 | 2,069,634 | SH | SOLE | 2,069,634 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 1,157 | 329,537 | SH | SOLE | 329,537 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 3,078 | 2,565,102 | SH | SOLE | 2,565,102 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 18,393 | 325,881 | SH | SOLE | 325,881 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 13,680 | 4,653,000 | SH | SOLE | 4,653,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 201 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 5,776 | 761,971 | SH | SOLE | 761,971 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 985 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 328 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 31,509 | 1,304,741 | SH | SOLE | 1,304,741 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 17,641 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 2,250 | 98,593 | SH | SOLE | 98,593 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 27,108 | 3,557,507 | SH | SOLE | 3,557,507 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 132,566 | 4,968,756 | SH | SOLE | 4,968,756 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 97,777 | 2,223,212 | SH | SOLE | 2,223,212 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 5,317 | 115,236 | SH | SOLE | 115,236 | 0 | 0 |